CV Sciences, Inc. Receives NutraIngredients-USA 2021 Product of the Year: Immune Support Award

Jul 27, 2021

CV Sciences, Inc. and University of California, San Diego Publish Study of Cannabidiol Efficacy in Treating Nicotine Dependence

Jul 20, 2021

CV Sciences, Inc. Reports First Quarter 2021 Financial Results

May 13, 2021

CV Sciences, Inc. Announces Launch of PlusCBD™ Calm and Sleep Gummies

May 11, 2021

CV Sciences, Inc. to Announce First Quarter 2021 Results on May 13, 2021

May 6, 2021

CV Sciences and Alkemist Labs Form Partnership to Support the National Institute of Standards and Technology’s Cannabis Quality Assurance Program

Apr 13, 2021

CV Sciences, Inc. Reports Fiscal Year-End 2020 Financial Results

Mar 18, 2021

CV Sciences, Inc. to Announce Fiscal Year and Fourth Quarter 2020 Results on March 18, 2021

Mar 10, 2021

CV Sciences, Inc. Announces Launch of ProCBD™ Product Line

Jan 5, 2021

CV Sciences, Inc. Receives Nutritional Outlook’s 2020 Best of the Industry Award

Dec 10, 2020